Delivery Order SPE2DB22D9239-SPE2DB25FDH20
Award Date
3/14/25
Potential Completion Date
3/17/25
Potential Value
$43K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of XTANDI 40 MG CAPSULE 120S, a branded pharmaceutical product. The award has a ceiling value of $25,868.10 and a completion date of September 5, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of XTANDI 40 MG CAPSULE 120S, a specialty pharmaceutical product, with a ceiling value of $25,868.10. The contract is a firm fixed-price delivery order with a period of performance through January 8, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award...
This is a delivery order awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of XTANDI 40 MG CAPSULE 120S, with a ceiling value of $4,311.35 and a period of performance through July 3, 2024. The award is a firm fixed-price delivery order. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC)...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $43,113.50 order is for the delivery of XTANDI 40 MG CAPSULE 120S, with a completion date of May 20, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs through December 31, 2025. This single-award...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The $8,622.72 contract is for the delivery of 120 capsules of the pharmaceutical product XTANDI 40 MG. This delivery order was issued under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA, which runs through December 31, 2025. The IDC...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,311.35 contract is to provide 120 capsules of the medication XTANDI 40 MG. This delivery order is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This IDC allows the DLA to issue...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $25,868.10 contract is for the delivery of XTANDI 40 MG CAPSULE 120S, a prescription medication, and is not associated with any set-aside program. DMS Pharmaceutical Group holds a single-award indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, that allows...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $8,622.72 and is a firm fixed-price delivery order for the provision of 4,567,222,790 units of the prescription drug XTANDI 40 MG CAPSULE 120S. The contract does not have a set-aside designation and is part of a larger $499,999,999 Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order, valued at $4,311.35, is for the delivery of 4564325248 XTANDI 40 MG CAPSULE 120S. The delivery order is a firm fixed-price contract with an ultimate completion date of April 19, 2024. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $8,622.72 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 120 units of the pharmaceutical product XTANDI 40 MG CAPSULE. This order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA's Medical Supply Chain division, valued at up to $499,999,999. The IDC runs through December 31, 2025...